RecallRadar

FDA Device recall Z-3134-2026

MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))

On 2026-09-16 the FDA classified a Class II recall of MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X)) by Nipro Renal Soultions Usa, citing hemodialysis concentrates contain high endotoxin levels.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-3134-2026
ClassificationClass II
Statusongoing
Initiated2026-08-05
Published2026-09-16
Last updated2026-09-23 05:30 UTC
CompanyNipro Renal Soultions Usa
DistributionUS

Product

MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))

Reason

Hemodialysis concentrates contain high endotoxin levels

Identifiers

code_infoDB+201-2.1: Lot -NDB5E004(exp.4/30/2027) DB+201-25: Lots - NDB5M011(Exp.12/05/2027, NDB4J003(exp.9/25/2026)

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-23 05:30 UTC. Current status: ongoing.

Other recalls by Nipro Renal Soultions Usa

All Nipro Renal Soultions Usa recalls

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-3134-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.